Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue to challen...

Full description

Bibliographic Details
Main Authors: Loos, Carolin (Author), Atyeo, Caroline (Author), Fischinger, Stephanie (Author), Burke, John (Author), Slein, Matthew D. (Author), Streeck, Hendrik (Author), Lauffenburger, Douglas A (Author), Ryan, Edward T. (Author), Charles, Richelle C. (Author), Alter, Galit (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor)
Format: Article
Language:English
Published: American Society for Microbiology, 2020-09-08T15:59:20Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items